{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:55:03Z","timestamp":1777953303528,"version":"3.51.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R35GM124875"],"award-info":[{"award-number":["1R35GM124875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug combinations offer one potential strategy for slowing the evolution of antibiotic resistance. In this work, we investigate the evolution of drug resistance (strictly, the decrease in susceptibility) in populations of Enterococcus faecalis, an opportunistic human pathogen, exposed to different concentrations of the rarely used combination of linezolid (LZD) and levofloxacin (LEV). Using continuous culture bioreactors, we measured the two-dimensional dose\u2013response surface of ancestral populations of E. faecalis, revealing that the LZD\u2013LEV combination is strongly antagonistic, resulting in increased growth as LZD concentration is increased at a (sufficiently high) fixed concentration of LEV. Next, we performed multiday (50+ hour) evolution experiments by continually exposing populations to four different fixed-concentration combinations and then characterized isolates from adapted populations using whole genome sequencing and phenotypic dose\u2013response curves. To control for differences in inhibition levels for different concentration combinations, we chose LZD\u2013LEV combinations that fall along a single contour of constant growth in the two-drug space of LZD\u2013LEV concentrations. Despite similar levels of initial inhibition across the four concentration combinations, we found that adaption is markedly different, with the most rapid adaptation and highest levels of evolved resistance occurring at combinations that include a high concentration of one drug and low concentration of the other. By contrast, we found almost no adaptation when both drugs were used at high concentrations, an initially surprising result that can be explained by simple drug-rescaling arguments applied to the antagonistic dose\u2013response surface. Our results underscore the potential utility of a nonstandard (and strongly antagonistic) drug combination in suppressing resistance.<\/jats:p>","DOI":"10.1093\/femsmc\/xtaf020","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:01:53Z","timestamp":1766062913000},"source":"Crossref","is-referenced-by-count":0,"title":["Linezolid and levofloxacin: an uncommon pairing that suppresses evolution of resistance in\n                    <i>E. faecalis<\/i>"],"prefix":"10.1093","volume":"7","author":[{"given":"Noah M","family":"Schlachter","sequence":"first","affiliation":[{"name":"University of Michigan Department of Biophysics, , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-2655","authenticated-orcid":false,"given":"Keanu Guardiola","family":"Flores","sequence":"additional","affiliation":[{"name":"University of Michigan Department of Biophysics, , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-7401","authenticated-orcid":false,"given":"Kevin B","family":"Wood","sequence":"additional","affiliation":[{"name":"University of Michigan Department of Biophysics, , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"University of Michigan Department of Physics, , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-6800","authenticated-orcid":false,"given":"Jeff","family":"Maltas","sequence":"additional","affiliation":[{"name":"University of Maryland Department of Biology, , College Park, MD 20740 ,","place":["United States"]},{"name":"University of Maryland Department of Physics, , College Park, MD 20740 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026050410565686700_bib1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10096-023-04704-8","article-title":"Synergistic properties of linezolid against Enterococcus spp. isolates: a systematic review from in vitro studies","volume":"43","author":"Antonello","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026050410565686700_bib2","doi-asserted-by":"publisher","first-page":"e73250","DOI":"10.7554\/eLife.73250","article-title":"The population genetics of collateral resistance and sensitivity","volume":"10","author":"Ardell","year":"2021","journal-title":"eLife"},{"key":"2026050410565686700_bib3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2026050410565686700_bib4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/mdr.2018.0005","article-title":"Linezolid consumption facilitates the development of linezolid resistance in Enterococcus faecalis in a tertiary-care hospital: a 5-year surveillance study","volume":"25","author":"Bai","year":"2019","journal-title":"Microb Drug Resist"},{"key":"2026050410565686700_bib5","doi-asserted-by":"publisher","first-page":"e2004356","DOI":"10.1371\/journal.pbio.2004356","article-title":"Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model","volume":"16","author":"Barbosa","year":"2018","journal-title":"PLoS Biol"},{"key":"2026050410565686700_bib6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-1039","article-title":"Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq","volume":"15","author":"Barrick","year":"2014","journal-title":"BMC Genomics"},{"key":"2026050410565686700_bib7","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"2026050410565686700_bib8","first-page":"802","article-title":"Antibiotic cycling and antibiotic mixing: which one best mitigates antibiotic resistance?","volume":"34","author":"Beardmore","year":"2017","journal-title":"Mol Biol Evol"},{"key":"2026050410565686700_bib9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/cid\/ciy064","article-title":"A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis","volume":"67","author":"Beganovic","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026050410565686700_bib10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2009.10.025","article-title":"Nonoptimal microbial response to antibiotics underlies suppressive drug interactions","volume":"139","author":"Bollenbach","year":"2009","journal-title":"Cell"},{"key":"2026050410565686700_bib11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1086\/513876","article-title":"Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo","volume":"195","author":"Bourgeois-Nicolaos","year":"2007","journal-title":"J Infect Dis"},{"key":"2026050410565686700_bib12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nature05685","article-title":"Antibiotic interactions that select against resistance","volume":"446","author":"Chait","year":"2007","journal-title":"Nature"},{"key":"2026050410565686700_bib13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/ed.ed_18_23","article-title":"Clinico-microbiological profile on multidrug-resistant enterococci in urinary tract infection patients in a tertiary care hospital","volume":"9","author":"Chatterjee","year":"2024","journal-title":"Environ Dis"},{"key":"2026050410565686700_bib14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10096-019-03801-x","article-title":"Role of linezolid combination therapy for serious infections: review of the current evidence","volume":"39","author":"Chen","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026050410565686700_bib15","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/IDR.S181339","article-title":"Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis","volume":"11","author":"Chen","year":"2018","journal-title":"IDR"},{"key":"2026050410565686700_bib16","doi-asserted-by":"publisher","first-page":"e1002299","DOI":"10.1371\/journal.pbio.1002299","article-title":"Quantifying the determinants of evolutionary dynamics leading to drug resistance","volume":"13","author":"Chevereau","year":"2015","journal-title":"PLoS Biol"},{"key":"2026050410565686700_bib17","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","author":"Clewell","year":"2014"},{"key":"2026050410565686700_bib18","doi-asserted-by":"publisher","first-page":"e55155","DOI":"10.7554\/eLife.55155","article-title":"Predictable properties of fitness landscapes induced by adaptational tradeoffs","volume":"9","author":"Das","year":"2020","journal-title":"eLife"},{"key":"2026050410565686700_bib19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"2026050410565686700_bib20","doi-asserted-by":"publisher","first-page":"e1008278","DOI":"10.1371\/journal.ppat.1008278","article-title":"Antibiotic interactions shape short-term evolution of resistance in E. faecalis","volume":"16","author":"Dean","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026050410565686700_bib21","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1128\/AAC.00419-12","article-title":"Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis","volume":"56","author":"Diaz","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026050410565686700_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00058-18","article-title":"The Enterococcus: a model of adaptability to its environment","volume":"32","author":"Garc\u00eda-Solache","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2026050410565686700_bib23","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817923","volume-title":"The enterococci: pathogenesis, molecular biology, and antibiotic resistance","author":"Gilmore","year":"2002"},{"key":"2026050410565686700_bib24","doi-asserted-by":"publisher","first-page":"e64851","DOI":"10.7554\/eLife.64851","article-title":"Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance","volume":"10","author":"Gjini","year":"2021","journal-title":"eLife"},{"key":"2026050410565686700_bib25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"2026050410565686700_bib26","doi-asserted-by":"publisher","first-page":"13977","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments","volume":"105","author":"Hegreness","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026050410565686700_bib27","first-page":"2023","article-title":"Heterogeneous collateral effects in daptomycin-resistant E. faecalis","author":"Huynh","year":"2023","journal-title":"bioRxiv"},{"key":"2026050410565686700_bib28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","article-title":"Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections","volume":"172","author":"Imamovic","year":"2018","journal-title":"Cell"},{"key":"2026050410565686700_bib29","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026050410565686700_bib30","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3201\/eid1307.070019","article-title":"Response to emerging infection leading to outbreak of linezolid-resistant enterococci","volume":"13","author":"Kainer","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2026050410565686700_bib31","doi-asserted-by":"publisher","first-page":"e1011424","DOI":"10.1371\/journal.ppat.1011424","article-title":"Targeted IS-element sequencing uncovers transposition dynamics during selective pressure in enterococci","volume":"19","author":"Kirsch","year":"2023","journal-title":"PLoS Pathog"},{"key":"2026050410565686700_bib32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.chom.2024.03.005","article-title":"A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota","volume":"32","author":"Kirsch","year":"2024","journal-title":"Cell Host Microbe"},{"key":"2026050410565686700_bib33","article-title":"Enterococcal infection\u2014treatment and antibiotic resistance","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","author":"Kristich","year":"2014"},{"key":"2026050410565686700_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-022-05260-5","article-title":"Antibiotic combinations reduce Staphylococcus aureus clearance","volume":"610","author":"L\u00e1z\u00e1r","year":"2022","journal-title":"Nature"},{"key":"2026050410565686700_bib35","doi-asserted-by":"publisher","first-page":"e3002970","DOI":"10.1371\/journal.pbio.3002970","article-title":"Dynamic collateral sensitivity profiles highlight opportunities and challenges for optimizing antibiotic sequences","volume":"23","author":"Maltas","year":"2025","journal-title":"PLoS Biol"},{"key":"2026050410565686700_bib36","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/molbev\/msz303","article-title":"Using selection by nonantibiotic stressors to sensitize bacteria to antibiotics","volume":"37","author":"Maltas","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2026050410565686700_bib37","doi-asserted-by":"publisher","first-page":"e3000515","DOI":"10.1371\/journal.pbio.3000515","article-title":"Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance","volume":"17","author":"Maltas","year":"2019","journal-title":"PLoS Biol"},{"key":"2026050410565686700_bib38","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.0800944105","article-title":"Drug interactions modulate the potential for evolution of resistance","volume":"105","author":"Michel","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026050410565686700_bib39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026050410565686700_bib40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41467-018-08098-6","article-title":"Antibiotic collateral sensitivity is contingent on the repeatability of evolution","volume":"10","author":"Nichol","year":"2019","journal-title":"Nat Commun"},{"key":"2026050410565686700_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","article-title":"Collateral sensitivity of antibiotic-resistant microbes","volume":"23","author":"P\u00e1l","year":"2015","journal-title":"Trends Microbiol"},{"key":"2026050410565686700_bib42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrg3351","article-title":"Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance","volume":"14","author":"Palmer","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2026050410565686700_bib43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jgar.2020.01.010","article-title":"Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis","volume":"21","author":"Rodr\u00edguez-Noriega","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2026050410565686700_bib44","doi-asserted-by":"publisher","first-page":"e1009172","DOI":"10.1371\/journal.ppat.1009172","article-title":"Mechanisms and therapeutic potential of collateral sensitivity to antibiotics","volume":"17","author":"Roemhild","year":"2021","journal-title":"PLoS Pathog"},{"key":"2026050410565686700_bib45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08529-y","article-title":"Collateral sensitivity constrains resistance evolution of the CTX-M-15 \u03b2-lactamase","volume":"10","author":"Rosenkilde","year":"2019","journal-title":"Nat Commun"},{"key":"2026050410565686700_bib46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10410236.2014.943634","article-title":"Antibiotic resistance: a primer and call to action","volume":"30","author":"Smith","year":"2015","journal-title":"Health Commun"},{"key":"2026050410565686700_bib47","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.47.6.1902-1906.2003","article-title":"In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected Gram-negative organisms","volume":"47","author":"Sweeney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2026050410565686700_bib48","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nbt.4151","article-title":"Precise, automated control of conditions for high-throughput growth of yeast and bacteria with eVOLVER","volume":"36","author":"Wong","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2026050410565686700_bib49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1752-0509-6-48","article-title":"Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli","volume":"6","author":"Wood","year":"2012","journal-title":"BMC Syst Biol"},{"key":"2026050410565686700_bib50","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.celrep.2014.02.007","article-title":"Uncovering scaling laws to infer multidrug response of resistant microbes and cancer cells","volume":"6","author":"Wood","year":"2014","journal-title":"Cell Rep"},{"key":"2026050410565686700_bib51","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1093\/bioinformatics\/btx433","article-title":"ISEScan: automated identification of insertion sequence elements in prokaryotic genomes","volume":"33","author":"Xie","year":"2017","journal-title":"Bioinformatics"},{"key":"2026050410565686700_bib52","first-page":"GC07","article-title":"Linezolid and vancomycin resistant enterococci: a therapeutic problem","volume":"11","author":"Yadav","year":"2017","journal-title":"J Clin Diagnos Res"},{"key":"2026050410565686700_bib53","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1128\/JCM.05549-11","article-title":"Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections","volume":"49","author":"Yasufuku","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2026050410565686700_bib54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nrmicro2133","article-title":"Drug interactions and the evolution of antibiotic resistance","volume":"7","author":"Yeh","year":"2009","journal-title":"Nat Rev Microbiol"}],"container-title":["FEMS Microbes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/femsmicrobes\/advance-article-pdf\/doi\/10.1093\/femsmc\/xtaf020\/66002203\/xtaf020.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsmicrobes\/article-pdf\/doi\/10.1093\/femsmc\/xtaf020\/66002203\/xtaf020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsmicrobes\/article-pdf\/doi\/10.1093\/femsmc\/xtaf020\/66002203\/xtaf020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:57:06Z","timestamp":1777906626000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsmicrobes\/article\/doi\/10.1093\/femsmc\/xtaf020\/8383412"}},"subtitle":[],"editor":[{"given":"Breck","family":"Duerkop","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1093\/femsmc\/xtaf020","relation":{},"ISSN":["2633-6685"],"issn-type":[{"value":"2633-6685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,12,18]]},"article-number":"xtaf020"}}